| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.62B | -2.2% |
| Cost of Revenue | $7.01B | +2.5% |
| R&D Expense | $19.0M | +11.8% |
| SG&A Expense | $704.0M | -9.0% |
| Operating Income | $804.0M | -28.2% |
| Pre-tax Income | $582.0M | -34.3% |
| Income Tax | $139.0M | -39.3% |
| Net Income | $444.0M | -32.5% |
| EPS (Basic) | $1.48 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $261.0M | +66.2% |
| Accounts Receivable | $590.0M | -5.0% |
| Inventory | $1.77B | +0.7% |
| Current Assets | $2.92B | +5.0% |
| Total Assets | $11.78B | +5.7% |
| Current Liabilities | $2.24B | +17.9% |
| Long-term Debt | $5.43B | +7.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $841.0M | +0.1% |
| Investing Cash Flow | -$732.0M | -114.0% |
| Financing Cash Flow | -$18.0M | +96.3% |
| -31.5% |
| EPS (Diluted) | $1.48 | -31.5% |
| Stockholders' Equity |
| $3.34B |
| +10.8% |